Pilot study of high dose ICE (ifosfamide, carboplatin, etoposide) chemotherapy and autologous bone marrow transplant (ABMT) with neoR-transduced bone marrow and peripheral blood stem cells in patients with metastatic breast cancer

Hum Gene Ther. 1993 Jun;4(3):331-54. doi: 10.1089/hum.1993.4.3-331.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bone Marrow Transplantation*
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / pathology
  • Breast Neoplasms / surgery
  • Breast Neoplasms / therapy*
  • Cisplatin / administration & dosage
  • Clinical Protocols
  • Combined Modality Therapy
  • Drug Resistance / genetics
  • Etoposide / administration & dosage
  • Genetic Therapy
  • Genetic Vectors
  • Humans
  • Ifosfamide / administration & dosage
  • Neomycin / pharmacology
  • Pilot Projects
  • Retroviridae / genetics
  • Stem Cell Transplantation*
  • Transduction, Genetic*
  • Transplantation, Autologous

Substances

  • Etoposide
  • Neomycin
  • Cisplatin
  • Ifosfamide

Supplementary concepts

  • ICE protocol 1